Title 21, Part 250 — Special Requirements for Specific Human Drugs
11 sections
Section 250.11
Thyroid-containing drug preparations intended for treatment of obesity in humans.
Section 250.12
Stramonium preparations labeled with directions for use in self-medication regarded as misbranded.
Section 250.100
Amyl nitrite inhalant as a prescription drug for human use.
Section 250.101
Amphetamine and methamphetamine inhalers regarded as prescription drugs.
Section 250.102
Drug preparations intended for human use containing certain “coronary vasodilators”.
Section 250.103-250.104
§§ 250.103-250.104 [Reserved]
Section 250.105
Gelsemium-containing preparations regarded as prescription drugs.
Section 250.106-250.107
§§ 250.106-250.107 [Reserved]
Section 250.108
Potassium permanganate preparations as prescription drugs.
Section 250.201
Preparations for the treatment of pernicious anemia.
Section 250.250
Hexachlorophene, as a component of drug and cosmetic products.